| Dennis Wendell Holder Jr, MD | |
|
777 Hemlock St, Hospital Box 142, Macon, GA 31201-2102 | |
| (478) 633-7707 | |
| (478) 633-7879 |
| Full Name | Dennis Wendell Holder Jr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 777 Hemlock St, Macon, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992731210 | NPI | - | NPPES |
| 735500172A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 055758 (Georgia) | Primary |
| Entity Name | Oconee Regional Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316938459 PECOS PAC ID: 3577589522 Enrollment ID: O20051019000125 |
News Archive
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
A new study, jointly led by the University of Southampton and King's College London, has found a link between gum disease and greater rates of cognitive decline in people with early stages of Alzheimer's Disease.
In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States.
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
› Verified 1 days ago
| Entity Name | Central Georgia Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598126641 PECOS PAC ID: 5991004608 Enrollment ID: O20160502001926 |
News Archive
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
A new study, jointly led by the University of Southampton and King's College London, has found a link between gum disease and greater rates of cognitive decline in people with early stages of Alzheimer's Disease.
In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States.
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Wendell Holder Jr, MD 777 Hemlock St, Msc 142, Macon, GA 31201-2102 Ph: (478) 633-7707 | Dennis Wendell Holder Jr, MD 777 Hemlock St, Hospital Box 142, Macon, GA 31201-2102 Ph: (478) 633-7707 |
News Archive
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
A new study, jointly led by the University of Southampton and King's College London, has found a link between gum disease and greater rates of cognitive decline in people with early stages of Alzheimer's Disease.
In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States.
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
› Verified 1 days ago
Dr. Allison Harriott, MD MPH Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hospital Dr, Macon, GA 31217 Phone: 478-765-7000 | |
Dr. Philip Enrique Chung, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1550 College St, Macon, GA 31207 Phone: 678-790-0729 | |
Lisa Kirkland, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 350 Hospital Dr, Macon, GA 31217 Phone: 770-994-9326 Fax: 770-994-4747 | |
Lloyd Harrington, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Hemlock St, Msc 10, Macon, GA 31201 Phone: 478-633-7707 | |
Rao Chapala, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Charter Blvd Medical Building, Macon, GA 31210 Phone: 478-756-6131 | |
Nalini Ramaiya, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2410 Ingleside Ave, Macon, GA 31204 Phone: 478-845-7462 Fax: 855-791-3372 | |
Dr. Matthew Raymond Astin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 478-633-7707 |